Acrodermatitis chronica atrophicans differential diagnosis: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Anahita (talk | contribs)
2,868 edits
Anahita (talk | contribs)
2,868 edits
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 4: Line 4:
{{CMG}}; {{AE}} {{Anahita}}
{{CMG}}; {{AE}} {{Anahita}}
==Overview==
==Overview==
==Differentiating [Disease name] from other Diseases==
[[Acrodermatitis chronica atrophicans]] must be differentiated from [[Chronic (medical)|chronic]] [[venous insufficiency]], [[Chronic (medical)|chronic]] [[Ischemia|arterial insufficiency]], [[Superficial (human anatomy)|superficial]] [[thrombophlebitis]], [[frostbite]], [[morphea]], [[erysipelas]], [[acrocyanosis]] and [[granuloma annulare]].
*Based on the main presentation of a [[patient]] with [[acrodermatitis chronica atrophicans]] there are different [[differential diagnosis]]. The following are the most common [[differential diagnosis]] of [[acrodermatitis chronica atrophicans]]:<ref name="pmid33085436">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=33085436 | doi= | pmc= | url= }} </ref><ref name="pmid20132258">{{cite journal| author=Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A | display-authors=etal| title=Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. | journal=Clin Microbiol Infect | year= 2011 | volume= 17 | issue= 1 | pages= 69-79 | pmid=20132258 | doi=10.1111/j.1469-0691.2010.03175.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20132258  }} </ref>
 
==Differentiating [[acrodermatitis chronica atrophicans]] from other Diseases==
*Based on the main presentation of a [[patient]] with [[acrodermatitis chronica atrophicans]] there are different [[differential diagnosis]]. The following are the most common [[differential diagnosis]] of [[acrodermatitis chronica atrophicans]]:<ref name="pmid33085436">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=33085436 | doi= | pmc= | url= }} </ref><ref name="pmid20132258">{{cite journal| author=Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A | display-authors=etal| title=Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. | journal=Clin Microbiol Infect | year= 2011 | volume= 17 | issue= 1 | pages= 69-79 | pmid=20132258 | doi=10.1111/j.1469-0691.2010.03175.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20132258 }} </ref><ref name="pmid1928618">{{cite journal| author=Aberer E, Klade H, Hobisch G| title=A clinical, histological, and immunohistochemical comparison of acrodermatitis chronica atrophicans and morphea. | journal=Am J Dermatopathol | year= 1991 | volume= 13 | issue= 4 | pages= 334-41 | pmid=1928618 | doi=10.1097/00000372-199108000-00003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1928618  }} </ref><ref name="pmid32512846">{{cite journal| author=Scott JD| title=Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada. | journal=Healthcare (Basel) | year= 2020 | volume= 8 | issue= 2 | pages=  | pmid=32512846 | doi=10.3390/healthcare8020157 | pmc=7349802 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32512846 }} </ref>
**[[Chronic (medical)|Chronic]] [[venous insufficiency]]
**[[Chronic (medical)|Chronic]] [[venous insufficiency]]
**[[Chronic (medical)|Chronic]] [[Ischemia|arterial insufficiency]]
**[[Chronic (medical)|Chronic]] [[Ischemia|arterial insufficiency]]
Line 11: Line 13:
**[[Frostbite|Cold injury]] ([[Frostbite]])
**[[Frostbite|Cold injury]] ([[Frostbite]])
**[[Livedoid vasculitis]]
**[[Livedoid vasculitis]]
**[[Scleroderma|Localized scleroderma]]
**[[Scleroderma|Localized scleroderma]] (also known as [[morphea]])
**[[Erysipelas]]
**[[Erysipelas]]
**[[Erysipeloid]]
**[[Lymphedema]]
**[[Lymphedema]]
**[[Chronic (medical)|Chronic]] potent [[topical]] [[corticosteroids]] use
**[[Chronic (medical)|Chronic]] potent [[topical]] [[corticosteroids]] use
Line 18: Line 21:
**[[Aging]]
**[[Aging]]
**[[Chilblain]]
**[[Chilblain]]
**[[Granuloma annulare]]
**[[Systemic sclerosis]]
*[[diagnosis|Misdiagnosis]] of [[rheumatoid arthritis]] may occur due to [[joint]] deformities and [[fibrosis|fibrotic]] [[Nodule (medicine)|nodules]].<ref name="pmid20132258">{{cite journal| author=Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A | display-authors=etal| title=Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. | journal=Clin Microbiol Infect | year= 2011 | volume= 17 | issue= 1 | pages= 69-79 | pmid=20132258 | doi=10.1111/j.1469-0691.2010.03175.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20132258  }} </ref>
*[[diagnosis|Misdiagnosis]] of [[rheumatoid arthritis]] may occur due to [[joint]] deformities and [[fibrosis|fibrotic]] [[Nodule (medicine)|nodules]].<ref name="pmid20132258">{{cite journal| author=Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A | display-authors=etal| title=Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. | journal=Clin Microbiol Infect | year= 2011 | volume= 17 | issue= 1 | pages= 69-79 | pmid=20132258 | doi=10.1111/j.1469-0691.2010.03175.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20132258  }} </ref>


Line 23: Line 28:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Needs review]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Dermatology]]
[[Category:Dermatology]]

Latest revision as of 10:59, 16 June 2021

Acrodermatitis chronica atrophicans Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Acrodermatitis chronica atrophicans from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acrodermatitis chronica atrophicans differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acrodermatitis chronica atrophicans differential diagnosis

CDC on Acrodermatitis chronica atrophicans differential diagnosis

Acrodermatitis chronica atrophicans differential diagnosis in the news

Blogs on Acrodermatitis chronica atrophicans differential diagnosis

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Acrodermatitis chronica atrophicans differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]

Overview

Acrodermatitis chronica atrophicans must be differentiated from chronic venous insufficiency, chronic arterial insufficiency, superficial thrombophlebitis, frostbite, morphea, erysipelas, acrocyanosis and granuloma annulare.

Differentiating acrodermatitis chronica atrophicans from other Diseases

References

  1. ↑ "StatPearls". 2021. PMID 33085436 Check |pmid= value (help).
  2. ↑ 2.0 2.1 Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A; et al. (2011). "Lyme borreliosis: clinical case definitions for diagnosis and management in Europe". Clin Microbiol Infect. 17 (1): 69–79. doi:10.1111/j.1469-0691.2010.03175.x. PMID 20132258.
  3. ↑ Aberer E, Klade H, Hobisch G (1991). "A clinical, histological, and immunohistochemical comparison of acrodermatitis chronica atrophicans and morphea". Am J Dermatopathol. 13 (4): 334–41. doi:10.1097/00000372-199108000-00003. PMID 1928618.
  4. ↑ Scott JD (2020). "Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada". Healthcare (Basel). 8 (2). doi:10.3390/healthcare8020157. PMC 7349802 Check |pmc= value (help). PMID 32512846 Check |pmid= value (help).

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Acrodermatitis_chronica_atrophicans_differential_diagnosis&oldid=1704359"